Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationAlternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationDifferent doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantationClinical indications for thrombopoietin and thrombopoietin-receptor agonistsImproving platelet transfusion safety: biomedical and technical considerationsIndications for platelet transfusion in patients with thrombocytopeniaWhere did platelets go in 2012? A survey of platelet transfusion practice in the North of EnglandWhy has demand for platelet components increased? A reviewPathogen inactivation technologies for cellular blood components: an updateAlternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.Haematological cancer: Prophylactic platelet transfusion is frequently not necessary.Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review.Intracranial haemorrhage in thrombocytopenic haematology patients--a nested case-control study: the InCiTe study protocolImmature platelet fraction measured on the Sysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantationProspective observational cohort study of the association between thromboelastometry, coagulation and platelet parameters and bleeding in patients with haematological malignancies- the ATHENA study.ST-elevation myocardial infarction and myelodysplastic syndrome with acute myeloid leukemia transformationImpact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.Platelet transfusion strategy for hematologic cancers.Platelet transfusion in hematology, oncology and surgery.Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy.Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis.Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unitA study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.A whole blood model of thrombocytopenia that controls platelet count and hematocrit.Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot studyWide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States.Bleeding After Endoscopic Procedures in Patients With Chronic Hematologic Thrombocytopenia.Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation.Antithrombotic therapy and platelet transfusions in hematologic malignancy patients presenting chemotherapy-induced thrombocytopenia: a French survey.The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia.A pathogen reduction clinical trial in retrospectTransfusion medicine as of 2014.Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic LeukemiaComparison of a therapeutic-only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders.Italian daily platelet transfusion practice for haematological patients undergoing high dose chemotherapy with or without stem cell transplantation: a survey by the GIMEMA Haemostasis and Thrombosis Working Party.Toward a patient-based paradigm for blood transfusion.
P2860
Q24186359-DFF1FAC6-8634-45A2-9BF2-955FBD363769Q24186913-F663A63A-A93C-4C6A-BB9A-5408ADFB9373Q24187751-B43EDAD1-232E-4687-8778-8133D7BE7316Q24198288-A02B32FF-3760-4D3D-BDB2-053A2CC5168AQ24198774-5CD38AD1-3E4E-4657-82F7-CCFB378BC892Q24198795-A81D2856-6EA5-4C3D-AA36-6D861A185E66Q24198832-84423049-6839-4A3E-9294-CA21C5395B26Q24601161-1029480D-5049-462F-AE11-F6F8E50496D3Q26775408-9EEF4966-4679-4DBF-BF10-F233089A857BQ27023734-3682FB43-42FA-4AED-BE35-DEC697508277Q28242680-E0539A02-C234-4FB9-8EF8-50FD71367619Q28249969-B679B5BF-7E4A-4EC9-A83E-245E6E1DEE7FQ28655769-F20E4CAE-EB03-46B1-BE53-0C7E36EE3666Q30248355-7F0680DE-FF89-4D0B-8595-380780724B6BQ33408843-77E1C329-2FF3-4C62-8C16-7283BAEADAF4Q33410860-E48094F6-2D65-4AF7-8BE9-24A920C2759CQ33413225-56F11217-B38C-4B8C-8CED-DAB6CC075BD1Q33414161-5C0F5CA0-B6DC-45FE-BEC3-1F54E692D8E0Q33415057-AFBDA574-A007-4356-8009-FB3CC0142433Q33415153-96627B76-3C84-4131-98A6-BECB47CBEE6BQ33417080-AA2C5445-81FF-4A39-9B49-3A9D6256798DQ33418477-7F7ABAD3-FD62-43A7-BBAB-47AA02CC90DDQ33419351-2D9068A8-FB64-49B8-A782-B21DCA092767Q33419425-A9F609FA-C4F1-4FB1-B996-49F4F823DE82Q33421355-912CBB4A-5C6A-4CAC-A428-FFF6D801AE7DQ33427993-EAE8C2AB-A113-49CB-9D99-DF2788877764Q33429565-491320FC-8693-49F9-8393-FA32378A4F2CQ33434527-9B6548DB-B9A2-4B40-8CFB-95B7C272C965Q33436425-AFF62FC4-A63F-418D-B5CA-CF8976CC333BQ33437019-1B94C419-D25A-43F0-A1F7-1AA97CC2B5F5Q33438003-EAFBC6A0-1BA2-4D2A-8439-FAF90F128569Q33438699-4BB026F7-56D2-4F00-8B3F-D5DCF7E527DCQ33441333-45E56EF3-0147-4F2C-9830-3A4DD6A13F70Q33442126-7B845A1F-92C7-4153-934B-9A36EC84911FQ33852525-3ACC1037-BD5D-4055-B396-FA82EACFC064Q34500022-BAD79693-DEE3-4C02-824F-2465EDBB3ED1Q35904994-0E77A41C-1651-4EC5-A6D6-FCC6C50E56EFQ37265484-7A139827-9995-4609-B770-7727410C3CB5Q37417311-4DEB831D-3539-47EF-94FE-3EE397DDB997Q37568315-D623FA55-A462-470D-8018-FED9CB171A92
P2860
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Therapeutic platelet transfusi ...... multicentre, randomised study.
@ast
Therapeutic platelet transfusi ...... multicentre, randomised study.
@en
type
label
Therapeutic platelet transfusi ...... multicentre, randomised study.
@ast
Therapeutic platelet transfusi ...... multicentre, randomised study.
@en
prefLabel
Therapeutic platelet transfusi ...... multicentre, randomised study.
@ast
Therapeutic platelet transfusi ...... multicentre, randomised study.
@en
P2093
P50
P1433
P1476
Therapeutic platelet transfusi ...... multicentre, randomised study.
@en
P2093
Anne Klenner
Anthony Ho
Bettina Pilz
Christian Junghanss
Gottfried Dölken
Hannes Wandt
Kerstin Schaefer-Eckart
Knut Wendelin
Lothar Leimer
Markus Schaich
P304
P356
10.1016/S0140-6736(12)60689-8
P407
P577
2012-08-08T00:00:00Z